Neuroimmune Response to Lipopolysaccharide

计划入组 27 人 · 首次发布于 2020 年 1 月 18 日

Neuroimmune Mechanisms in Obesity

首次发布于 2022 年 9 月 23 日

Peripheral Neuroimmune Mechanisms of Hyperthermia

计划入组 60 人 · 首次发布于 2022 年 5 月 9 日

Reximmune-C

AAV hmAb(Neurimmune Therapeutics)

PM-10 (MedImmune)

NexImmune, Inc.

United States

Neurimmune AG

Switzerland

MedImmune Ltd.

United Kingdom

ProteoNic's 2G UNic Technology Licensed by Ginkgo Bioworks for $22.2M BARDA-Funded Anti-Filovirus Antibody Manufacturing Project

Biogen Sues Neurimmune Over Rights to Novel Alzheimer's Bispecific Antibody Technology

NexImmune Advances NEX-ILE12 Immunotherapy in Phase 1 Trials with Promising Safety Profile